Clinical Trial Perspective: Cost-effectiveness of Transcatheter Mitral Valve Repair Versus Medical Therapy in Patients with Heart Failure and Secondary Mitral Regurgitation. Results From the COAPT Trial
Treatment of secondary (or functional) mitral regurgitation had traditionally been limited to optimal medical therapy because studies have failed to show a survival benefit with mitral valve surgery for this condition. However, recently the Cardiovascular Outcomes Assessment of the MitraClip Percuta...
Guardado en:
Autor principal: | Suzanne J Baron |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Radcliffe Medical Media
2020
|
Materias: | |
Acceso en línea: | https://doaj.org/article/e0e84d83a3ef428481b119afc5e50faf |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Treatment of Secondary Mitral Regurgitation in Heart Failure: A Shifting Paradigm in the Wake of the COAPT Trial
por: Kelly H Schlendorf, et al.
Publicado: (2020) -
Transcatheter mitral valve repair devices - in vitro studies on the influence of device-width on mitral regurgitation
por: Ott Robert, et al.
Publicado: (2020) -
Assessment of mitral regurgitation and mitral complex geometry in patients after transcatheter aortic valve implantation
por: Danuta Sorysz, et al.
Publicado: (2020) -
Mitral surgical redo versus transapical transcatheter mitral valve implantation.
por: Alina Zubarevich, et al.
Publicado: (2021) -
Effect of Operator Experience on Transcatheter Mitral Valve Repair Outcomes
por: Justin P Sheehy, et al.
Publicado: (2021)